BFG
TNGX icon

Bleakley Financial Group’s Tango Therapeutics TNGX Stock Holding History

Bleakley Financial Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$259K Buy
+12,381
New +$172K ﹤0.01% 728
2025
Q1 		– Sell
-12,849
Closed -$39.7K – 955
2024
Q4 		$39.7K Sell
12,849
-1,578
-11% -$7.33K ﹤0.01% 1026
2024
Q3 		$111K Sell
14,427
-1,653
-10% -$15.8K ﹤0.01% 963
2024
Q2 		$138K Buy
+16,080
New +$124K ﹤0.01% 931

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Bleakley Financial Group's TNGX Position: Q1 2026 in Review

Bleakley Financial Group opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 12,381 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #728 among its holdings. This is a return to the name: Bleakley Financial Group previously reported a position in TNGX as recently as Q4 2024.

Bleakley Financial Group first reported a position in TNGX in Q2 2024 and has held it in 4 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Bleakley Financial Group held 12,381 shares of Tango Therapeutics worth $259K as of Q1 2026.
  • Tango Therapeutics was a new Bleakley Financial Group position in Q1 2026.
  • Tango Therapeutics made up ﹤0.01% of Bleakley Financial Group's portfolio in Q1 2026, its #728 holding.
  • Bleakley Financial Group first reported a position in Tango Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Bleakley Financial Group's 13F filing for Q1 2026, filed 4 May 2026.